Abstract
Gastroparesis is a syndrome characterized by delayed gastric emptying in the absence of mechanical obstruction of the stomach. The three most common etiologies of gastroparesis are diabetes, postsurgical, and idiopathic (i.e., of unknown cause). Symptoms associated with gastroparesis include nausea, vomiting, postprandial fullness, early satiety, bloating, and/or abdominal pain. Asymptomatic cases of delayed gastric emptying can be seen; particularly, in diabetic patients where difficult to control glucoses can be associated with the onset of delayed gastric emptying. The true prevalence of gastroparesis is difficult to estimate due to the relatively poor correlation of symptoms with gastric emptying and the need to apply a diagnostic test to diagnose this condition in a community setting. It is unclear if the majority of patients with gastroparesis seek health care or how often they are referred to gastroenterologists, and therefore the true prevalence of gastroparesis is not known. Community studies of the outcome of gastroparesis are few, and studies conducted in tertiary referral centers may not reflect findings encountered in the general population. Estimates for the prevalence of gastroparesis have been approximately 4%, based on the prevalence of functional dyspepsia in the community (20%) and the prevalence of delayed gastric emptying in patients with functional dyspepsia (20%). However, in a recent epidemiologic study of Olmsted County, Minnesota, the prevalence of gastroparesis was lower with the prevalence of definite gastroparesis (symptomatic individual with delayed gastric emptying) reported to be 9.6 per 100,000 for men and 37.8 per 100,000 for women.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1589–91.
Talley NJ, Locke III GR, Lahr BD, et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut. 2006;55:933–9.
Parkman HP, Camilleri M, Farrugia G, et al. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil. 2010;22(2):113–33.
Jung HK, Choung RS, Locke III GR, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225–33.
Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med. 1958;48:797–812.
Jones KL, Russo A, Berry MK, et al. A longitudinal study of gastric emptying and upper Âgastrointestinal symptoms in patients with diabetes mellitus. Am J Med. 2002;113:449–55.
Kong MF, Horowitz M, Jones KL, et al. Natural history of diabetic gastroparesis. Diabetes Care. 1999;22:503–7.
Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and longterm follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398–404.
Pasricha PJ, Nguyen L, Snape WJ, Colvin R, Lee LA, Abell TL, Koch KL, Parkman HP, Tonascia J, Analp-Arida A, Hasler WL, Farrugia G, Hamilton FA. Changes in quality of life and symptoms in a large cohort of patients with gastroparesis followed prospectively for 48 weeks. Gastroenterol. 2010;112:98 (abstract).
Abell TL, Camilleri M, DiMagno EP, Hench VS, Zinsmeister AR, Malagelada JR. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci. 1991;36(5):616–20.
Cutts TF, Luo J, Starkebaum W, Rashed H, Abell TL. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil. 2005;17(1):35–43.
Anand C, Al-Juburi A, Familoni B, Rashed H, Cutts T, Abidi N, et al. Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers. Digestion. 2007;75(2–3):83–9.
Lin Z, Sarosiek I, Forster J, McCallum RW. Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol Motil. 2006;18(1):18–27.
Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995–2004. Am J Gastroenterol. 2008;103(2):313–22.
Uppalapati SS, Ramzan Z, Fisher RS, Parkman HP. Factors contributing to hospitalization for gastroparesis exacerbations. Dig Dis Sci. 2009;54(11):2404–9.
Rayner CK, Horowitz M. New management approaches for gastroparesis. Nat Clin Pract Gastroenterol Hepatol. 2005;2(10):454–62.
Schvarcz E, Palmer M, Aman J, et al. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology. 1997;113:60–6.
Jones KL, Horowitz M, Berry M, et al. Blood glucose concentration influences postprandial fullness in IDDM. Diabetes Care. 1997;20:1141–6.
Nathan DM, Cleajy PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.
The Diabetes Control and Complications Trial [DCCT] Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.
UK Prospective Diabetes Study [UKPDS] group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.
Bytzer P, Talley NJ, Hammer J, et al. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97:604–11.
Talley NJ, Bytzer P, Hammer J, Young L, Jones M, Horowitz M. Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001;96:1033–8.
Hyett B, Martinez FJ, Gill BM, Mehra S, et al. Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology. 2009;137(2):445–52.
Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic Âgastroparesis-clinical characteristics and long-term outcomes. Am J Gastroenterol. 1997;92(9):1501–4.
Hasler W, Wilson L, May K, Parkman H, Abell T, Koch K, Snape W, Nguyen L, McCallum R, Pasricha P, Farrugia G, Tonascia J, Lee L, Unalp-Arida A, Hamilton F, and the NIDDK GpCRC. Post-infectious gastroparesis: differences in baseline and clinical characteristics and evolution of symptoms and disease severity after 48 weeks versus patients without infectious prodromes. Gastroenterol. 2011;114:343 (abstract).
Hejazi RA, Sarosiek I, Roeser K, et al. Does grading the severity of gastroparesis based on scintigraphic gastric emptying predict the treatment outcome of patients with gastroparesis? Dig Dis Sci. 2011;56:1147–53.
McCallum R, Lin Z, Wetzel P, Sarosiek I, Forster J. Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis. Clin Gastroenterol Hepatol. 2005;3:49–54.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hejazi, R.A., Parkman, H.P., McCallum, R.W. (2012). Natural History of Patients with Gastroparesis. In: Parkman, H., McCallum, R. (eds) Gastroparesis. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-60761-552-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-60761-552-1_8
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-551-4
Online ISBN: 978-1-60761-552-1
eBook Packages: MedicineMedicine (R0)